Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junling Gu

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Current Issues in Molecular Biology|September 29, 2025
Sodium Butyrate Ameliorated Bile Acid Metabolism in Diabetes Mellitus by PI3K/AKT Signaling Pathway via the Gut-Liver AxisTingting Zhao, Xi Zhang, Qian Xiang, et al.
Journal of Diabetes Research|February 17, 2016
High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial CellsHong Feng, Junling Gu, Fang Gou, et al.
Oxidative Medicine and Cellular Longevity|July 30, 2020
Sodium Butyrate-Modulated Mitochondrial Function in High-Insulin Induced HepG2 Cell DysfunctionTingting Zhao, Junling Gu, Huixia Zhang, et al.
Oxidative Medicine and Cellular Longevity|February 9, 2023
High Glucose-Induced Kidney Injury via Activation of Necroptosis in Diabetic Kidney DiseaseMan Guo, Qing Chen, Yongli Huang, et al.
Chinese Medicine|February 13, 2022
Intake of flavonoids from Astragalus membranaceus ameliorated brain impairment in diabetic mice via modulating brain-gut axisXuling Li, Tingting Zhao, Junling Gu, et al.
Journal of Advanced Research|August 15, 2024
Gut microbiota-derived indole-3-propionic acid alleviates diabetic kidney disease through its mitochondrial protective effect via reducing ubiquitination mediated-degradation of SIRT1Yan Zeng, Man Guo, Qi Wu, et al.
Heliyon|March 20, 2023
Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathwaysTingting Zhao, Qian Xiang, Beifeng Lie, et al.
Journal of Diabetes|April 11, 2025
Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Active Comparator StudyLi Liu, Zhifeng Cheng, Lianwei Wang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Current Issues in Molecular Biology|September 29, 2025
Sodium Butyrate Ameliorated Bile Acid Metabolism in Diabetes Mellitus by PI3K/AKT Signaling Pathway via the Gut-Liver AxisTingting Zhao, Xi Zhang, Qian Xiang, et al.
Journal of Diabetes Research|February 17, 2016
High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial CellsHong Feng, Junling Gu, Fang Gou, et al.
Oxidative Medicine and Cellular Longevity|July 30, 2020
Sodium Butyrate-Modulated Mitochondrial Function in High-Insulin Induced HepG2 Cell DysfunctionTingting Zhao, Junling Gu, Huixia Zhang, et al.
Oxidative Medicine and Cellular Longevity|February 9, 2023
High Glucose-Induced Kidney Injury via Activation of Necroptosis in Diabetic Kidney DiseaseMan Guo, Qing Chen, Yongli Huang, et al.
Chinese Medicine|February 13, 2022
Intake of flavonoids from Astragalus membranaceus ameliorated brain impairment in diabetic mice via modulating brain-gut axisXuling Li, Tingting Zhao, Junling Gu, et al.
Journal of Advanced Research|August 15, 2024
Gut microbiota-derived indole-3-propionic acid alleviates diabetic kidney disease through its mitochondrial protective effect via reducing ubiquitination mediated-degradation of SIRT1Yan Zeng, Man Guo, Qi Wu, et al.
Heliyon|March 20, 2023
Yishen Huashi granule modulated lipid metabolism in diabetic nephropathy via PI3K/AKT/mTOR signaling pathwaysTingting Zhao, Qian Xiang, Beifeng Lie, et al.
Journal of Diabetes|April 11, 2025
Efficacy and Safety of Dulaglutide Biosimilar LY05008 Versus the Reference Product Dulaglutide (Trulicity) in Chinese Adults With Type 2 Diabetes Mellitus: A Randomized, Open-Label, Active Comparator StudyLi Liu, Zhifeng Cheng, Lianwei Wang, et al.
Pageof 2